The Effects of Allicin on Weight in Fructose-Induced Hyperinsulinemic, Hyperlipidemic, Hypertensive Rats

American Journal of Hypertension

Volumn 16, Issue 12, 2003, Pages 1053-1056

  Elkayam, Amitai ^a   Mirelman, David ^b   Peleg, Edna ^a   Wilchek, Meir ^b   Miron, Talia ^b   Rabinkov, Aharon ^b   Oron Herman, Mor ^a   Rosenthal, Talma ^a,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALLICIN; CARBOHYDRATE; FAT; FRUCTOSE; GARLIC OIL; INSULIN; POTASSIUM; PROTEIN; SODIUM; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; GARLIC; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WEIGHT; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0345059218     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2003.07.011     Document Type: Article

References (27)

1. Chopra RN, Chopra IC, Handa KL, Kapur LD: Indigenous Drugs of India Allium satiun L, 2nd ed. Dhure and Sons, Calcutta, 1951, pp 271 (cited by Bordia).
2. Schery RW: Plants for Man. Prentice-Hall, Englewood, NJ, 1972.
3. Mirelman D, Wilchek M, Miron T, Rabinhov A, Sivarman H: Immobilized Allinase and Continuous Production of Allicin. PCT Publication No. WO 97/39115, 1997.
4. Eilat S, Oestraicher Y, Rabinkov A, Ohad D, Mirelman D, Baitler A, Eldar N, Vered Z: Alteration of lipid profile in hyperlipidemic rabbits by allicin, an active constituent of garlic. Coron Artery Dis 1995;6:985-990.
5. Elkayam A, Mirelman D, Peleg E, Wilchek M, Miron T, Rabinkov A, Sadetzki T, Rosenthal T: The effect of allicin and enalapril in fructose induced hyperinsulinemic hyperlipidemic hypertensive rats. J Hypertens 2001;14:377-381.
6. Mirelman D, Monheit D, Steuart V: Inhibition of growth of Enthamoeba histolitica by allicin, the active principle of garlic extract (Allium Satinum). J Infect Dis 1987;156:243-244.
7. Hirsch K, Danilenko M, Giat J, Miron T, Rabinkov A, Wilcheck M, Mirelman D, Levy J, Sharoni Y: Effect of purified allicin in major ingredient of freshly crushed garlic, on cancer cell proliferation. Nutr Cancer 2000;38:245-254.
8. Yanovski SZ, Yanovski JA: Obesity. New Engl J Med 2002;346: 591-602.
9. Stoll A, Seebeck E: Chemical investigations of Allin, the specific principle of garlic. Adv Enzymol 1951;11:377.
10. Reaven GM: Insulin resistance, hyperinsulinemia and hypertriglyceridemia in the etiology and clinical course of hypertension. Am J Med 1991;90(Suppl 2A):7-12.
11. Zavaroni I, Chen YDI, Reaven GM: Studies on the mechanism of fructose induced hypertriglyceridemia in the rat. Metabolism 1982; 31:1077-1083.
12. Erlich Y, Rosenthal T: Effect of angiotensin-converting enzyme inhibitors on fructose-induced hypertension and hyperinsulinemia in rats. Clin Exp Pharmacol Physiol 1995;27(Suppl 1):S347-S349.
13. Erlich Y, Rosenthal T: Contribution of nitric oxide to the beneficial effects of converting enzyme inhibitors. Hypertension 1996; 28:754-757.
14. Bordia AK, Sanadhya JYK, Bhu N: Effect of essential oil of garlic on serum fibrinolytic activity in patients with coronary artery disease. Atherosclerosis 1977;28:15-19.
15. Kieswetter H, Jung F, Morwietz C, Pindur G, Heiden M, Wenzel E: Effect of garlic on blood fluidity and fibrinolytic activity: a randomised placebo-controlled double-blind study. Br J Clin Pract 1990; 69(Suppl):24-29.
16. Lawson LD, Hughes BG: Inhibition of whole platelet aggregation by compounds in garlic clove extracts and commercial products. Thromb Res 1992;65:141-156.
17. Augusti KT, Mathew PT: Lipid lowering effect of allicin (diallyl disulphide oxide) on long term feeding to normal rats. Experientia 1974;30:468-470.
18. Bordia A, Arora SK, Kothari LK, Jain KC, Rathore BS, Rathore AS: The protective action of essential oils of onion and garlic in cholesterol-fed rabbits. Atherosclerosis 1975;22:103-109.
19. Bordia A, Verma SA: Effect of garlic feeding on regression of experimental atherosclerosis in rabbits. Artery 1980;7:428-437.
20. Knipschild JK, Ter-Riet G: Garlic, onions and cardiovascular risk factors. A review of the evidence from human experiments. Emphasis on commercially available preparations. Br J Clin Pharmacol 1989;28:535-544.
21. Nakagawa H, Tsuta K, Kiuchi K, Senzaki H, Tanaka K, Hioki K, Tsubura A: Growth inhibitory effects of diallyl disulfide on human cancer cell lines. Carcinogenesis 2001;22:891-897.
22. Tsao SM, Yin C: In-vitro antimicrobial activity of four diallyl sulfides occurring naturally in garlic and Chinese leek oils. J Med Microbiol 2001;50:646-649.
23. Ide N, Lau BH: Garlic compounds protect vascular endothelial cells from oxidized low density lipoprotein-induced injury. J Pharm Pharmacol 1997;49:908-911.
24. Efendy JL, Simmons DL, Campbell GR, Campbell JH: The effect of the aged garlic extract, 'Kyolic', on the development of experimental atherosclerosis. Atherosclerosis 1997;132:37-42.
25. Lee YS: A comparative study of the effect of allicin and arsenite on albino rats with special regard to the effect on body weight, hemoglobin, and hepatic histology. N Engl J Med 1967;1:99-101.
26. Yanovski SZ, Yanovski JA: Obesity. N Engl J Med 2002;346:591-602.
27. Methods for voluntary weight loss and control. NIH Technology Assessment Conference Panel. Consensus Development Conference, 30 March to 1 April 1992. Ann Intern Med 1993;119(7 Pt 2):764-770.